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Reverse transcriptase PCRAbstract Implantation of biomaterials poses a huge risk of local inﬂammation therefore affecting
the implant function leading to mortality in a signiﬁcant number of cases. Thus, alternatively, nat-
urally derived drugs if developed to treat implant induced inﬂammation, would therefore sharply
decrease the largest risk of implant rejection. This study was aimed to investigate the anti inﬂamma-
tory effect of Withania somnifera on stainless steel implant induced inﬂammation in adult zebraﬁsh
model. Fish were divided into four experimental groups of 6 ﬁsh each. Group 1 served as the control;
Group 2 ﬁsh were stainless steel implant (SSI) inserted ﬁsh without treatment; Group 3 ﬁsh were SSI
inserted + Thin layer chromatography (TLC) separated portion of supernatant ofW. somnifera and
Group 4 ﬁsh were SSI inserted + Ibuprofen treated. Fish were assessed for reduced inﬂammation by
histopathology, local apoptosis using ﬂuorescent quantiﬁcation, reverse transcriptase polymerase
chain reaction (RT-PCR) of inﬂammatory genes. The characterization of the TLC separated portion
of the supernatant of W. somnifera was also performed. The histopathology result of Group 2
showed crypt architectural distortion in the muscle which was not found in the control ﬁsh, whereas
simultaneously TLC separated portion of the supernatant of W. somnifera showed reduced fatty
changes and ﬁbrosis of the submucosa, muscular hyperplasia. RT-PCR result revealed that the
TLC separated portion of supernatant of W. somnifera has a signiﬁcant inhibition of TNFa in the
adult zebraﬁsh. In conclusion the observed anti-inﬂammatory activity of TLC separated portion
of the supernatant of W. somnifera might be due to rich phenolic acids and ﬂavonoids.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Academy of Scientific Research &
Technology.1. Introduction
Implants are increasingly used in many types of surgery, to im-
prove impaired function, replace missing an anatomic struc-
ture, or optimize appearance [9,11,12]. Among the materials
which are used for bone repair, stainless steel is a metal with
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ical strength. Implantation of biomaterials poses a huge risk of
local inﬂammation therefore affecting implant function lead-
ing to mortality in a signiﬁcant number of cases. The inﬂam-
matory process is of great medical importance since it occurs
in 70% of human and domestic animal pathologies and being,
with rare exceptions [27], an essential physiological mechanism
for the maintenance of homoeostasis. To treat inﬂammatory
processes non-steroidal anti-inﬂammatory drugs (NSAIDs)
are widely used. NSAID when consumed under sub chronic
and chronic conditions exerts adverse effects and has also been
proven to alter the bio-availability of other prescribed drugs.
Thus, alternatively, naturally derived drugs if developed to
treat implant induced inﬂammation, would therefore sharply
decrease the largest risk of implant rejection.
Since the beginning of human civilization, medicinal plants
have been used by mankind for its therapeutic value. Nature
has been a source of medicinal agents for thousands of years
and an impressive number of modern drugs have been isolated
from natural sources. Many of these isolations were based on
the uses of the agents in traditional medicine. The plant-based,
traditional medicine systems continue to play an essential role
in health care, with about 80% of the world’s inhabitants rely-
ing mainly on traditional medicines for their primary health
care [24]. Withania somnifera is one of the major herbal com-
ponents of geriatric tonics mentioned in Indian systems of
medicine [29]. In the traditional system of medicine Ayurveda,
this plant is claimed to have potent aphrodisiac rejuvenative
and life prolonging properties. It has general animating and
regenerative qualities and is used among others for the treat-
ment of nervous exhaustion, memory related conditions,
insomnia, tiredness potency issues, skin problems and cough-
ing. It improves learning ability and memory capacity.
Studies show ashwagandha to be effective in the treatment
of osteoarthritis [15], inﬂammation [2,18], stroke [3] and tar-
dive dyskinesia [7]. Studies also reveal ashwagandha to be a
potential antimicrobial agent, with antifungal activity [1,5]
and moderate antibacterial activity against Staphylococcus
aureus and Pseudomonas aeruginosa [8]. Several studies have
examined the antitumor and radio sensitizing effect ofW. som-
nifera [13,14,21,22].
The present study aimed to identify and quantify the ﬂavo-
noids and phenolic acid from W. somnifera leaf extracts using
Thin layer chromatography (TLC), High performance liquid
chromatography (HPLC) and also evaluate the anti-inﬂamma-
tory activity of W. somnifera against stainless steel implant in-
duced inﬂammation in adult zebraﬁsh. The zebraﬁsh is a small
tropical freshwater ﬁsh living in India and South Asia. It is
widely known to aquarium fans. Traditionally this ﬁsh was
used in molecular genetics and developmental biology; now
it attracts much attention in studies on the development of
new drugs and modeling of various physiological and patho-
logical processes [4,10,17,19,23,26].
2. Material and methods
2.1. Chemicals and solvents
The chemicals, solvents and drugs were of analytical grade and
were purchased from Hi-Media Laboratories Pvt. Ltd (Mum-
bai, India) and Merck Chemicals Company, MO, USA.2.2. Plant collection and processing
The medicinal plant, Ashwagandha (W. somnifera) was col-
lected from the local market, Chennai, Tamil Nadu. The aerial
parts of the plant were washed with tap water, rinsed with dis-
tilled water and air dried under shaded light with good venti-
lation at room temperature for a few minutes.
2.3. Sample preparation for TLC and HPLC
The fresh plant leaves (3 g) were extracted with 10 mL of meth-
anol:water (3:7) solvents for 15 min. The samples were centri-
fuged at 3000 rpm for 10 min. The supernatants were collected
and ﬁltered through Whatman (No. 1) ﬁlter paper. The ﬁl-
trates were used for chromatographic separation.
2.4. TLC separation of plant leaves extract
About 300 ll of the sample was spotted on the TLC plates and
the chromatogram was developed using butanol:glacial acetic
acid:water solvent in a ratio of 4:1:5. The TLC separated col-
oured spots of plant extracts were scraped and dissolved in
1 mL water and centrifuged at 4000 rpm for 5 min. The super-
natants were taken and their absorbances were recorded at
700–200 nm and stored at 20 C until completion of the
study.
2.5. HPLC analysis of TLC separated portion of W. Somnifera
The prepared samples were also quantiﬁed by using reversed
phase HPLC on Nova-Pak C-18 (Waters associates, Milford,
MA) column (4.6 mm · 24 cm) using methanol, water and
phosphoric acid (100:100:1) mixture as mobile phase and UV
detection (200–450 nm) at a ﬂow rate of 1 mL/min was used.
The chromatogram was compared with the chromatogram of
standards.
2.6. Animals and maintenance
Zebraﬁsh of uniform size of length (2.6 ± 0.2 cm) and weight
(1.15 ± 0.1 g) were segregated from the stock and acclima-
tized for 10 days to lab conditions, temperature
(27 ± 2 C), pH (7.5–7.8) and almost normal photoperiod
(12:12-h L/D). The ﬁsh were divided into four groups of
six each. Group 1. Control (CON): Control ﬁsh. Group 2.
Stainless steel implanted (SSI): Implants of uniform size of
length (0.3 ± 0.06 mm) and thickness (0.8 ± 0.06 mm) in-
serted into the smooth unstriated muscle of ﬁsh without
treatment. Group 3. SSI +W. Somnifera: 3 SSI inserted ﬁsh
received 300 lL of TLC separated portion of supernatant of
W. somnifera (through passive diffusion). Group 4.
SSI + Ibuprofen: SSI inserted ﬁsh received 300 lL Ibuprofen
(through passive diffusion).
At the end of the experimental period the ﬁsh were sacri-
ﬁced by decapitation. Blood was collected and muscle was ex-
cised immediately and processed for analysis. The work has
been carried out in strict consideration with ethical standards
of the Institutional Animal Ethics Committee of the Madras
Medical Mission (IAEC of MMM).
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The SSI inserted zebraﬁsh motility was monitored with 10X vi-
deo camera.
2.8. Acridine orange/Ethidium bromide (AO/EtBr) staining
The zebraﬁsh were collected from each experimental group and
anesthesizedby ice-coldwater (15 C).Themuscles of SSIﬁshwere
removedandchopped into small pieces in5 mlofRPMImediaand
allowed to stand for a few minutes to settle the cell debris, and the
supernatant was collected. The supernatants were centrifuged at
5000 rpm for 10 min and the pellets were resuspended in 1X phos-
phate buffered saline (PBS). About 20 lLof the sample was added
into 20 lL of AO/EtBr. The samples were transferred into a glass
slide using a syringe and a cover slip was placed on top of the drop.
The glass slides were viewed under ﬂuorescent microscope at 10X.
2.9. Histopathological analysis
A portion of implant inserted muscle was removed and ﬁxed in
10% formalin ﬂuid and sectioned using a microtome, andFigure 1 HPLC Chromatogram of standard ﬂavonoids (a), standard
somnifera (c). The retention time for standard ﬂavonoids such as R
(16.460), Agigenein (31.000) and retention time for phenolic acids su
(6.243), and Benzoic acid (7.823) were compared with the chromatogr
which showed the presence of phenolic acid and ﬂavonoids.dehydrated in graded alcohol, embedded in parafﬁn section
and stained with hemotoxylin and eosin (H&E). The lesions
in the muscle were examined in ten randomly selected sections
of each tissue from each ﬁsh. All samples were examined under
a light microscope (Nikon YS100), and photomicrographs
were taken with a digital camera at its highest resolution.
2.10. Total RNA extraction
About 300–500 mg of muscle tissues were weighed and homog-
enized in a 5 mL of Lysis buffer and centrifuged at 12,000 rpm
for 3 min. The supernatants were collected in fresh polypropyl-
ene vials. 1 mL of supernatant was mixed with equal volume of
water saturated phenol (15 mL of phenol in 35 mL of water
and aqueous layer was removed and phenol layer was used
as water saturated phenol) and 200 lL of chloroform–Isoamyl
alcohol (49:1) was mixed and vortexed for 10 s and incubated
at RT for 15 min and centrifuged at 12,000 rpm for 15 min at
4 C for RNA extraction. The colourless upper aqueous phase
was transferred into a new polypropylene vial and mixed with
500 lL of cooled 100% (v/v) iso amyl alcohol and incubated at
20 C for 30 min and centrifuged at 12,000 rpm for 30 min atphenolic acid (b) and TLC separated portion of supernatant ofW.
utein (3.820), Quercetin (6.057), Kaempferol (11.483), Luteolin
ch as Gallic acid (4.823), Vanillic acid (5.710), p-Coumaric acid
am of TLC separated portion of the supernatant of W. somnifera
4 S. Sivamani et al.4 C for RNA precipitation. The supernatant was discarded
and a white precipitate of the RNA pellet was dried at room
temperature for 5–10 min to remove the content of iso amyl
alcohol. The pellet was ﬁnally dissolved with 10–15 lL of 1X
Tris–acetic acid–EDTA (TAE) buffer. The RNA samples were
stored at 20 C until the completion of the experiment.
2.11. Complementary DNA (cDNA) synthesis
An equal amount of total RNA was taken for cDNA synthesis.
RNA was mixed with 3 lL of oligo-deoxy-thymine (oligo-DT),
5 lLof reverse transcriptase (MuLv-RT), and 10 lL1XTEbuffer
(10 mMTris–HCl; pH 8.5, 1 mMETDA) and vortexed and incu-
bated at 37 C for 30 min. The reaction was halted by denaturing
the MuLv-RT at 55 C for 3 h. cDNA was stored at 20 C.
2.12. Reverse transcription polymerase chain reaction (RT-
PCR)
The expression level of cytokines TNFa was quantiﬁed by RT-




Fig. 1 represents the HPLC chromatogram of standard and
TLC separated portions of the supernatant of W. somnifera.Figure 2 Fluorescence photomicrographs depict the local apoptosis
nuclei structure (b) SSI inserted showed cells shrinkage, chromatin cond
supernatant of W. Somnifera showed less cell shrinkage and chromatinThe ﬂavonoids and phenolic acid content of the TLC sepa-
rated portion of W. somnifera were quantiﬁed by HPLC using
standard ﬂavonoids: Rutein, Quercetin, Kaempferol, Luteolin,
Agigenein (Fig. 1a) and standard phenolic acid: Gallic acid,
Vanillic acid, p-Coumaric acid, Benzoic acid. Sharp peaks
for ﬂavonoids and phenolic acid such as Gallic acid, Rutein,
Vanillic acid, Quercetin, Kaempferol were obtained in the
TLC separated portion of the supernatant of W. somnifera
(Fig. 1c), and the concentrations of observed phenolic acid
and ﬂavonoids were found to be 7.3, 5.1, 46.6, 5.1 and
0.20 mg/dL, respectively.
3.2. AO/EtBr staining
Fig. 2 shows the presence of live cells and dead cells both in the
experimental group and the control. The percentage of live
cells is represented by green colour and dead cells by red col-
our. It was observed that the control ﬁsh has a greater number
of live cells and the implant inserted ﬁsh has a greater number
of apoptotic cells, whereas W. Somnifera extract treated has a
greater number of live cells.
3.3. Histopathology study
Fig. 3 represents the histology of the control and experimental
ﬁsh. The H&E staining of the smooth unstriated muscle clearly
showed crypt architectural distortion of the mucosa, focal
mucosal ulceration (arrowhead), fatty change (*) and ﬁbrosislevels in the control and test animals. (a) Control cells with intact
ensation in the nuclei whereas, (c) SSI + TLC separated portion of
condensation (d) SSI + Ibuprofen served as the negative control.
Figure 3 H&E staining of the muscle in control and experimental ﬁsh. (a) Normal smooth unstriated muscle architecture of control ﬁsh.
The SSI ﬁsh (b) showed crypt architectural distortion of the mucosa, focal mucosal ulceration (arrowhead), fatty change (*) and ﬁbrosis of
the submucosa, muscular hyperplasia (arrows), and partial effacement of normal layers of the bowel wall which were not found in the
control ﬁsh, whereas TLC separated portion of the supernatant of W. somnifera showed reduced fatty changes and ﬁbrosis of the
submucosa, muscular hyperplasia. Ibuprofen received ﬁsh (d) showed normal morphology.
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effacement of normal layers of the bowel wall in SSI inserted
ﬁsh; these changes were found to be reduced in the simulta-
neous TLC separated portion of the supernatant ofW. somnif-
era treated ﬁsh. Control (Fig. 3a) and Ibuprofen received ﬁsh
(Fig. 3d) showed normal morphology.
3.4. RT-PCR
To explore whether cytokines were involved in the inﬂamma-
tion process, the expression level of TNFa (Nucleotide se-
quences of forward primer 50CCC AGG CAG TCA GAT
CAT CTT C30 and reverse primer 50AGC TGC CCC TCA
GCT TGA30) is critical for humoral and cellular immunity,
was selectively examined by RT-PCR. The result showed that
the administration of W. somnifera extract strongly enhanced
the expression of cytokines (Fig. 4).Figure 4 Reverse transcription PCR. The expression of TNFa in
the experimental group zebraﬁsh [Lane 1: Control group ﬁsh;
Lane 2: SSI inserted ﬁsh; Lane 3: SSI + TLC separated portion of
supernatant ofW. somnifera treated ﬁsh; Lane 4: SSI + Ibuprofen
treated ﬁsh].4. Discussion
Conventional NSAIDs are the most commonly prescribed
agents used for the management of inﬂammation and pain,
however, toxic manifestation associated with these agents is
a matter of concern. As a result, several new approaches are
now considered for the design and development of superior
anti-inﬂammatory compounds, showing fewer side effects. In
the present study, we have evaluated the anti-inﬂammatory
activity ofW. somnifera against stainless steel implant induced
inﬂammation. The methanolic fraction of the W. somnifera
when administered up to a dose of 1000 mg/kg, produced no
visible side effects or death, and the dose range was found to
be well tolerated in the treated groups.
Carrageenan induced rat paw oedema, is a well-accepted and
popular model for evaluating anti-inﬂammatory activity. Carra-
geenan is known to produce a biphasic response [28], where the
early phase is related to the production of histamine, leukotri-
enes’, platelet activating factor (PAF) and possibly cyclooxygen-
ase products, while the delayed phase is linked to the neutrophil
inﬁltration, eicosanoid release and the production of free radi-
cals and also the release of other neutrophil derived mediators
[11]. Interestingly NSAIDs may not be effective in reducing
the inﬂammation in the later phase of such oedema formation,
[6]. In the present study, TLC separated portion of supernatant
of W. somnifera produced signiﬁcant and also dose dependent
inhibition of SSI induced inﬂammation.
Table 1 Effect of TLC separated portion of supernatant of
W. somnifera on stainless steel implant inserted muscle gene
expression of control and experimental ﬁsh.
Primer Experimental group
CON SSI SSI +WS SSI + IB
TNFa 7.36 ± 0.21 7.98 ± 0.24a 7.68 ± 0.70b 7.66 ± 0.16
The expression values are measured by ImageJ software. The values
are means ± SD (n= 6 in each group). a(p< 0.05) as compared to
CON. b(p< 0.05) as compared to SSI. Data within the groups were
analyzed using a one-way analysis of variance (ANOVA) followed
by the Duncan’s Multiple Range Test (DMRT). CON, control; SSI,
stainless steel implant inserted; WS, TLC separated portion of W.
somnifera; IB, Ibuprofen.
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migrating to the site of injury are known to produce the super-
oxide radical O2 , which in turn leads to the generation of
hydrogen peroxide. Furthermore, in the presence of suitable
transitional elements, hydrogen peroxide may be transformed
to the highly reactive hydroxyl radical. These radicals can also
act as second messengers, thereby activating the production of
other inﬂammatory mediators [15,16].
Reactive oxygen species are known to activate a number of
intracellular signaling pathways such as NF-kB (nuclear factor
kappa-light-chain-enhancer of activated B cells), which in turn
activates the transcription of various pro-inﬂammatory cyto-
kines (interleukins and TNFa), cell adhesion molecules and also
COX 2 [25]. Consistent with a role for NF-kB in the transcrip-
tional activation of genes encoding TNF-a mRNA levels were
increased in the SSI inserted zebraﬁsh. Similarly, TLC separated
portion of the supernatant ofW. somnifera treated zebraﬁsh was
mirrored by a reduction in TNF-amRNA levels. In conformity
with these ﬁndings,W. somnifera derived ﬂavonoids and pheno-
lic acid such as gallic acid, rutein, vanillic acid, quercetin and
kaempferol block distinct signal transduction events necessary
for NF-kB activation. The molecular activities of ﬂavonoids
and phenolic acids include inhibition of transcription factors
such asNF-kB and activating protein-1 (AP-1), as well as activa-
tion of nuclear factor-erythroid 2-related factor 2 (Nrf2) [20].
Our study with TLC separated portion of supernatant of
W. somnifera revealed signiﬁcant inhibition of TNFa in adult
zebraﬁsh. The expression values were found to be 7.36 ± 0.21,
7.98 ± 0.24, 7.68 ± 0.70, 7.66 ± 0.16 in experimental group
(Table 1).
Thus, on the basis of the present ﬁndings we can suggest
that the observed anti-inﬂammatory activity of TLC separated
portion of the supernatant of W. somnifera might be due to
rich phenolic acids and ﬂavonoids.Acknowledgement
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